NCT01530308View on ClinicalTrials.gov

Haloperidol Prophylaxis in Older Emergency Department Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

October 31, 2015

Conditions
Delirium
Interventions
DRUG

Haloperidol

An oral dosage of 1mg twice daily at 12am and 8pm.

DRUG

Placebo

An oral dosage of 1mg twice-daily at 12am and 8 pm.

Trial Locations (6)

5223 GZ

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

1007 MB

VUmc, Amsterdam

2134 TM

Spaarne Ziekenhuis, Hoofddorp

Unknown

Medical Center Alkmaar, Alkmaar

2353 GA

Rijnland Ziekenhuis, Leiderdorp

8011 JW

Isala Klinieken, Zwolle

All Listed Sponsors
lead

Amsterdam UMC, location VUmc

OTHER

NCT01530308 - Haloperidol Prophylaxis in Older Emergency Department Patients | Biotech Hunter | Biotech Hunter